This site is intended for healthcare professionals

Immuno-oncotherapy News 1/2021 Slovak edition

Lenvatinib plus Pembrolizumab or Everolimus for Advanced Renal Cell Carcinoma

Immuno-oncotherapy News 1/2021 Slovak edition

Background Lenvatinib in combination with pembrolizumab or everolimus has activity against advanced renal cell carcinoma. The efficacy of these regimens as compared with that of sunitinib is unclear.   Methods In this phase 3 trial, we randomly assigned (in a 1:1:1 ratio) patients with advanced renal cell carcinoma and no previous systemic therapy to receive…

Zpět

Ortopédia a traumatológia nohy a členok dospelého veku

23 | 09 | 2025

V týchto dňoch vychádza už 6. zväzok Albertovej sbírky.

HOME Journal 2/2025

18 | 09 | 2025

Práve vyšlo nové číslo časopisu HOME Journal.

Cystická fibróza 1/2025

07 | 07 | 2025

V júli vyjde prvé tohtoročné číslo časopisu Cystická fibróza.




Partneři projektu